Literature DB >> 19048396

Expression of EphA2 and E-cadherin in gastric cancer: correlated with tumor progression and lymphogenous metastasis.

Weijie Yuan1, Zhikang Chen, Shaobin Wu, Jie Ge, Shi Chang, Xianwei Wang, Jingxiang Chen, Zihua Chen.   

Abstract

In this study, gastric cancer progression was correlated with the over-expression of erythropoietin-producing hepatocellular (Eph)A2 receptor and down-expression of epithelial cadherin (E-cadherin). Immunohistochemistry of EphA2 and E-cadherin were performed on these tumor samples from 165 primary lesions of gastric cancer. The results showed that expression of EphA2 was obviously increased in gastric cancer tissues (P < 0.01), which was positively correlated with the depth of cancer invasion, tumor-node-metastasis (TNM) stage and lymph node metastasis (P < 0.05). Meanwhile, the expression of E-cadherin was significantly reduced (P < 0.01), which was negatively correlated with the depth of cancer invasion, grade of tumor differentiation, TNM stage and lymph node metastasis (P < 0.05). The correlation between EphA2 and E-cadherin expression was negative (r = -0.198, P = 0.011). In conclusion, either the over-expression of EphA2 or the down-expression of E-cadherin is correlated with cancer progression and lymphogenous metastasis in gastric cancer, suggesting that both of them may play an important role in tumor progression and metastasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19048396     DOI: 10.1007/s12253-008-9132-y

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  37 in total

1.  Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder.

Authors:  Shaji Abraham; Deborah W Knapp; Liang Cheng; Paul W Snyder; Suresh K Mittal; Dinesh S Bangari; Michael Kinch; Lan Wu; Jay Dhariwal; Sulma I Mohammed
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

2.  Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival.

Authors:  A Jawhari; S Jordan; S Poole; P Browne; M Pignatelli; M J Farthing
Journal:  Gastroenterology       Date:  1997-01       Impact factor: 22.682

3.  MCF-10A-NeoST: a new cell system for studying cell-ECM and cell-cell interactions in breast cancer.

Authors:  N D Zantek; J Walker-Daniels; J Stewart; R K Hansen; D Robinson; H Miao; B Wang; H J Kung; M J Bissell; M S Kinch
Journal:  Clin Cancer Res       Date:  2001-11       Impact factor: 12.531

4.  High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia.

Authors:  Guangyuan Zeng; Zhiqiang Hu; Michael S Kinch; Chong-Xian Pan; David A Flockhart; Chinghai Kao; Thomas A Gardner; Shaobo Zhang; Lang Li; Lee Ann Baldridge; Michael O Koch; Thomas M Ulbright; John N Eble; Liang Cheng
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

5.  EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma.

Authors:  Tatsuya Miyazaki; Hiroyuki Kato; Minoru Fukuchi; Masanobu Nakajima; Hiroyuki Kuwano
Journal:  Int J Cancer       Date:  2003-02-20       Impact factor: 7.396

6.  EphA2 overexpression promotes ovarian cancer growth.

Authors:  Chunhua Lu; Mian M K Shahzad; Hua Wang; Charles N Landen; Seung W Kim; Julie Allen; Alpa M Nick; Nicholas Jennings; Michael S Kinch; Menashe Bar-Eli; Anil K Sood
Journal:  Cancer Biol Ther       Date:  2008-04-19       Impact factor: 4.742

7.  The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells.

Authors:  Jonathan Rios-Doria; Kathleen C Day; Rainer Kuefer; Michael G Rashid; Arul M Chinnaiyan; Mark A Rubin; Mark L Day
Journal:  J Biol Chem       Date:  2002-10-19       Impact factor: 5.157

8.  Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas.

Authors:  Hui-Chun Chen; Ricky Y Chu; Ping-Ning Hsu; Ping I Hsu; Jau-Yeong Lu; Kwok-Hung Lai; Hui-Hwa Tseng; Nan-Hua Chou; Ming-Shyan Huang; Ching-Jiunn Tseng; Michael Hsiao
Journal:  Cancer Lett       Date:  2003-11-10       Impact factor: 8.679

9.  Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1.

Authors:  V Noë; B Fingleton; K Jacobs; H C Crawford; S Vermeulen; W Steelant; E Bruyneel; L M Matrisian; M Mareel
Journal:  J Cell Sci       Date:  2001-01       Impact factor: 5.285

10.  E-cadherin mediates adhesion and suppresses cell motility via distinct mechanisms.

Authors:  H Chen; N E Paradies; M Fedor-Chaiken; R Brackenbury
Journal:  J Cell Sci       Date:  1997-02       Impact factor: 5.285

View more
  27 in total

1.  Complementary expression and repulsive signaling suggest that EphB receptors and ephrin-B ligands control cell positioning in the gastric epithelium.

Authors:  Kazushige Ogawa; Natsuki Takemoto; Maki Ishii; Elena B Pasquale; Takayuki Nakajima
Journal:  Histochem Cell Biol       Date:  2011-09-30       Impact factor: 4.304

2.  Global molecular dysfunctions in gastric cancer revealed by an integrated analysis of the phosphoproteome and transcriptome.

Authors:  Tiannan Guo; Sze Sing Lee; Wai Har Ng; Yi Zhu; Chee Sian Gan; Jiang Zhu; Haixia Wang; Shiang Huang; Siu Kwan Sze; Oi Lian Kon
Journal:  Cell Mol Life Sci       Date:  2010-10-16       Impact factor: 9.261

3.  Ephrin receptor (Eph) -A1, -A2, -A4 and -A7 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.

Authors:  Stamatios Theocharis; Jerzy Klijanienko; Constantinos Giaginis; Paraskevi Alexandrou; Efstratios Patsouris; Xavier Sastre-Garau
Journal:  Pathol Oncol Res       Date:  2013-09-11       Impact factor: 3.201

4.  MicroRNA 520d-3p inhibits gastric cancer cell proliferation, migration, and invasion by downregulating EphA2 expression.

Authors:  Ruixin Li; Weijie Yuan; Wenjuan Mei; Keda Yang; Zihua Chen
Journal:  Mol Cell Biochem       Date:  2014-07-26       Impact factor: 3.396

5.  EphA2 as a new target for breast cancer and its potential clinical application.

Authors:  Lingzhi Zhou; Xuejing Lu; Bensi Zhang; Yaqi Shi; Zhuang Li
Journal:  Int J Clin Exp Pathol       Date:  2021-04-15

6.  Expression of Eph A4, Eph B2 and Eph B4 receptors in AML.

Authors:  Tomasz Wrobel; Joanna Pogrzeba; Ewa Stefanko; Marcin Wojtowicz; Bozena Jazwiec; Justyna Dzietczenia; Grzegorz Mazur; Kazimierz Kuliczkowski
Journal:  Pathol Oncol Res       Date:  2014-04-25       Impact factor: 3.201

7.  Cancer-associated fibroblasts promote gastric tumorigenesis through EphA2 activation in a ligand-independent manner.

Authors:  Hea Nam Hong; You Jin Won; Ju Hee Shim; Hyun Ji Kim; Seung Hee Han; Byung Sik Kim; Hee Sung Kim
Journal:  J Cancer Res Clin Oncol       Date:  2018-06-12       Impact factor: 4.553

Review 8.  Eph-dependent cell-cell adhesion and segregation in development and cancer.

Authors:  Eva Nievergall; Martin Lackmann; Peter W Janes
Journal:  Cell Mol Life Sci       Date:  2011-12-28       Impact factor: 9.261

9.  Overexpression of EphA2 correlates with epithelial-mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients.

Authors:  Futao Hou; Weijie Yuan; Jin Huang; Liyuan Qian; Zhikang Chen; Jie Ge; Shaobin Wu; Jinxiang Chen; Jixu Wang; Zihua Chen
Journal:  Med Oncol       Date:  2011-12-22       Impact factor: 3.064

10.  Clinical significance of ephrin (eph)-A1, -A2, -a4, -a5 and -a7 receptors in pancreatic ductal adenocarcinoma.

Authors:  Constantinos Giaginis; Gerasimos Tsourouflis; Adamantia Zizi-Serbetzoglou; Gregorios Kouraklis; Elli Chatzopoulou; Konstantina Dimakopoulou; Stamatios E Theocharis
Journal:  Pathol Oncol Res       Date:  2009-12-01       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.